Milkyway Pharmaceuticals Private Limited

Milkyway Pharmaceuticals Private Limited - trading in Mandya, Karnataka, India. FY 2026 financials & compliance.
CIN U33114KA2014PTC073013 Incorporated 13 January 2014 ROC Bangalore HQ Mandya, Karnataka, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2025
₹72.57 Lakh
▲ 161% YoY
Net profit · FY 2025
₹2.12 Lakh
Net margin 2.9%
EBITDA · FY 2025
₹2.21 Lakh
EBITDA margin 3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.15 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Milkyway Pharmaceuticals Private Limited

Data last updated:

Milkyway Pharmaceuticals Private Limited is a private limited company based in Mandya, Karnataka, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 13 January 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33114KA2014PTC073013. Its GSTIN is 29AAJCM0780B1ZK (Karnataka).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.15 Lakh. It is led by directors including Lingappa Mohan Kumar (Managing Director) and Raghavendra Prasad.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 2nd Cross Jayalakshmi Theator Opp. Guttalu, Mandya, Karnataka, India – 571403.

As per the financials filed for FY 2025, the company reported a revenue of ₹72.57 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.12 Lakh (net margin 2.9%) and EBITDA of ₹2.21 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 131% over three years and 73% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U33114KA2014PTC073013
Registration Number 073013
Incorporation Date 13 January 2014
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant

Contact details

Milkyway Pharmaceuticals Private Limited's registered office is in Mandya, Karnataka. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    2nd Cross Jayalakshmi Theator Opp. Guttalu, Mandya, Karnataka, India – 571403
  • Industry
    Trading, Wholesale, Other Wholesale

To see the full contact details of Milkyway Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Milkyway Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Milkyway Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles45Wholesale and retail trade and repair of motor vehicles and motorcycles

To see the full business activity and turnover split of Milkyway Pharmaceuticals Private Limited, buy the company report.

Financials of Milkyway Pharmaceuticals Private Limited

FY 2024 filings available

Milkyway Pharmaceuticals Private Limited reported revenue of ₹72.57 Lakh (up 161% YoY) for FY 2025.

Revenue · FY 2025
₹72.57 Lakh ▲ 161%
Net profit · FY 2025
₹2.12 Lakh margin 2.9%
EBITDA · FY 2025
₹2.21 Lakh margin 3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 161%
3 years · compounded
▲ 131%
5 years · compounded
▲ 73%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▲ 61%
5 years · compounded
▲ 109%

Revenue has grown at a compounded annual rate (CAGR) of 73% over five years, including 161% growth in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.21 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.12 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3%
Net Profit Margin2.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Milkyway Pharmaceuticals Private Limited, buy the company report.

Board of directors of Milkyway Pharmaceuticals Private Limited

Milkyway Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Lingappa Mohan KumarManaging Director13 Jan 201412 Years 9 MonthsCurrent
Raghavendra PrasadDirector13 Jan 201412 Years 9 MonthsCurrent
Malavalli Nagaiah AnilkumarDirector13 Jan 201412 Years 9 MonthsCurrent

Auditor

Milkyway Pharmaceuticals Private Limited is audited by L.R. PRAKASH AND CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
L.R. PRAKASH AND CO.FY 2023002733S

Shareholding

The shareholding of Milkyway Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Milkyway Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Milkyway Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Milkyway Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAJCM0780B1ZKKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Milkyway Pharmaceuticals Private Limited, buy the company report.

Recent activity

Milkyway Pharmaceuticals Private Limited has 8 board changes on record since 2014: 3 appointments and 5 cessations. The latest: Shashi Kumar Javanegowdanadoddi Bommaiah ceased to be Director on 28 Nov 2018.

AGM
Milkyway Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Milkyway Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Ceased
Shashi Kumar Javanegowdanadoddi Bommaiah ceased to be Director.
Ceased
Boppanadu Boppanadu Pradeepa ceased to be Director.
Ceased
Kalenahalli Ramegowda Krishnegowda ceased to be Director.
Ceased
Kallimeledoddi Siddegowda Nandish ceased to be Additional Director.
Ceased
Manjunath Puttalingaiah ceased to be Additional Director.
Appointed
Lingappa Mohan Kumar was appointed as Managing Director.
Appointed
Malavalli Nagaiah Anilkumar was appointed as Director.
Appointed
Raghavendra Prasad was appointed as Director.
Incorporation
13 Jan 2014
Milkyway Pharmaceuticals Private Limited was registered on 13 Jan 2014 with Roc Bangalore & aged 12 years 9 months as per MCA records.

Frequently asked questions

Milkyway Pharmaceuticals is an active private limited company based in Mandya, Karnataka, India. The company works in wholesale, within the trading industry. It was incorporated on 13 January 2014 (12+ years old) and is registered under CIN U33114KA2014PTC073013.

Milkyway Pharmaceuticals has 3 current directors:

The latest financial statements of Milkyway Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Milkyway Pharmaceuticals is 29AAJCM0780B1ZK, registered in Karnataka.

The CIN (Corporate Identification Number) of Milkyway Pharmaceuticals is U33114KA2014PTC073013. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Milkyway Pharmaceuticals was incorporated on 13 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.

Shashi Kumar Javanegowdanadoddi Bommaiah ceased to be Director on 28 Nov 2018. Boppanadu Boppanadu Pradeepa ceased to be Director on 10 Sep 2017. Kalenahalli Ramegowda Krishnegowda ceased to be Director on 10 Sep 2017. Milkyway Pharmaceuticals has 8 board changes on record in total.

The registered office of Milkyway Pharmaceuticals is at 2nd Cross Jayalakshmi Theator Opp. Guttalu, Mandya, Karnataka, India – 571403.

Milkyway Pharmaceuticals operates in the trading industry, in the wholesale segment.

The compliance status of Milkyway Pharmaceuticals is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.